| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRC36 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | RP1-4G17.5 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | FOXD1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NOL3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | C1orf198 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | B3GNT2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BAG3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ZFYVE27 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | IFRD1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ABCE1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
